• Stefan SeregardEmail author
  • Maria Antonietta Blasi
  • Emilio Balestrazzi


The conjunctiva is a thin and moist mucous membrane. It covers the anterior part of the eye, saves the cornea, reaches peripherally into the upper and lower fornices, and then reflects to outline the inner surface of the eyelids. This sac remains incomplete at the bottom as the conjunctival epithelium transitions into the corneal epithelium, leaving the cornea devoid of conjunctival tissue unless pathology supervenes. At the top of the conjunctival sac, the interpalpebral fissure opens into the sac and the anterior ocular surface. The conjunctiva serves many purposes including some of great importance to ocular function. First, it secretes mucous material onto the ocular surface and contributes to the tear film. Second, it provides an anatomical and cellular barrier to foreign particles and bacteria.


Hereditary Hemorrhagic Telangiectasia Epidermolysis Bullosa Allergic Conjunctivitis Bulbar Conjunctiva Conjunctival Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Spencer WH. Conjunctiva. In: Spencer WH, editor. Ophthalmic pathology an atlas and textbook, vol. 1. 4th ed. Philadelphia: W.B. Saunders; 1996.Google Scholar
  2. 2.
    Jakobiec FA, Lam H, Bhat P, Pineda R. Non-syndromic supernumerary caruncles causing ocular irritation after cataract surgery: a critical review of caruncular dysgeneses. Am J Ophthalmol. 2010;149(3):398–404 e1–2.PubMedGoogle Scholar
  3. 3.
    Fraser GR. The pool of harmful genes in human populations. Acta Genet Med Gemellol (Roma). 1962;11:284–7.Google Scholar
  4. 4.
    McGregor L, Makela V, Darling SM, et al. Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet. 2003;34(2):203–8.PubMedGoogle Scholar
  5. 5.
    Vogel MJ, van Zon P, Brueton L, et al. Mutations in GRIP1 cause Fraser syndrome. J Med Genet. 2012;49(5):303–6.PubMedGoogle Scholar
  6. 6.
    Narang M, Kumar M, Shah D. Fraser-cryptophthalmos syndrome with colonic atresia. Indian J Pediatr. 2008;75(2):189–91.PubMedGoogle Scholar
  7. 7.
    Grover AK, Chaudhuri Z, Malik S, et al. Congenital eyelid colobomas in 51 patients. J Pediatr Ophthalmol Strabismus. 2009;46(3):151–9.PubMedGoogle Scholar
  8. 8.
    Sullivan TJ, Clarke MP, Morin JD. The ocular manifestations of the Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus. 1992;29(6):349–56.PubMedGoogle Scholar
  9. 9.
    Shields JA, Mashayekhi A, Kligman BE, et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology. 2011;118(9):1747–53.PubMedGoogle Scholar
  10. 10.
    Jakobiec FA, Pineda R, Rivera R, et al. Epicorneal polypoidal lipodermoid: lack of association of central corneal lesions with goldenhar syndrome verified with a review of the literature. Surv Ophthalmol. 2010;55(1):78–84.PubMedGoogle Scholar
  11. 11.
    Pokorny KS, Hyman BM, Jakobiec FA, et al. Epibulbar choristomas containing lacrimal tissue. Clinical distinction from dermoids and histologic evidence of an origin from the palpebral lobe. Ophthalmology. 1987;94(10):1249–57.PubMedGoogle Scholar
  12. 12.
    Chintakuntlawar AV, Chodosh J. Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis. Ocul Immunol Inflamm. 2010;18(5):341–5.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Rajak SN, Collin JR, Burton MJ. Trachomatous trichiasis and its management in endemic countries. Surv Ophthalmol. 2012;57(2):105–35.PubMedGoogle Scholar
  14. 14.
    Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl Trop Dis. 2013;7(2):e2020.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Clark GC, Moloney G, Sutton G. Ophthalmic presentation of Wegener’s granulomatosis on a background of polymyalgia rheumatica. Clin Experiment Ophthalmol. 2010;38(1):65–7.PubMedGoogle Scholar
  16. 16.
    Slack JW, Hyndiuk RA, Harris GJ, Simons KB. Blastomycosis of the eyelid and conjunctiva. Ophthal Plast Reconstr Surg. 1992;8(2):143–9.PubMedGoogle Scholar
  17. 17.
    Saenchez MD, Orita VM, Nolan TJ. Pathology in practice. Focally extensive granulomatous and eosinophilic conjunctivitis with numerous intralesional nematodes, consistent with Onchocerca spp. J Am Vet Med Assoc. 2012;240(4):385–7.PubMedGoogle Scholar
  18. 18.
    Rose JS, Arthur A, Raju R, Thomas M. Primary conjunctival tuberculosis in a 14 year old girl. Indian J Tuberc. 2011;58(1):32–4.PubMedGoogle Scholar
  19. 19.
    Kahana A, Marcet MM, Albert DM, Thliveris AT. Drug-induced cicatrising granulomatous conjunctivitis. Br J Ophthalmol. 2007;91(5):691–2.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Suzuki T. Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. Cornea. 2012;31 Suppl 1:S41–4.PubMedGoogle Scholar
  21. 21.
    Wong AH, Barg SS, Leung AK. Seasonal and perennial allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov. 2009;3(2):118–27.PubMedGoogle Scholar
  22. 22.
    Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11(5):477–82.PubMedGoogle Scholar
  23. 23.
    Srinivasan BD, Jakobiec FA, Iwamoto T, DeVoe AG. Giant papillary conjunctivitis with ocular prostheses. Arch Ophthalmol. 1979;97(5):892–5.PubMedGoogle Scholar
  24. 24.
    Korb DR, Allansmith MR, Greiner JV, et al. Biomicroscopy of papillae associated with hard contact lens wearing. Ophthalmology. 1981;88(11):1132–6.PubMedGoogle Scholar
  25. 25.
    Rohatgi J, Dhaliwal U. Phlyctenular eye disease: a reappraisal. Jpn J Ophthalmol. 2000;44(2):146–50.PubMedGoogle Scholar
  26. 26.
    Vieira AC, Hofling-Lima AL, Mannis MJ. Ocular rosacea–a review. Arq Bras Oftalmol. 2012;75(5):363–9.PubMedGoogle Scholar
  27. 27.
    Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22(3):230–3.PubMedGoogle Scholar
  28. 28.
    Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104(11):1863–7.PubMedGoogle Scholar
  29. 29.
    Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol. 2011;26(4–5):270–7.PubMedGoogle Scholar
  30. 30.
    Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy. 2012;97:149–66.PubMedGoogle Scholar
  31. 31.
    Rao R, Mellerio J, Bhogal BS, Groves R. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa. Indian J Dermatol Venereol Leprol. 2012;78(6):692–7.PubMedGoogle Scholar
  32. 32.
    Has C, Kiritsi D. Molecular therapies for epidermolysis bullosa. G Ital Dermatol Venereol. 2013;148(1):65–72.PubMedGoogle Scholar
  33. 33.
    Letko E, Bhol K, Anzaar F, et al. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. Arch Ophthalmol. 2006;124(11):1615–8.PubMedGoogle Scholar
  34. 34.
    Hunefeld C, Mezger M, Kern JS, et al. One goal, different strategies–molecular and cellular approaches for the treatment of inherited skin fragility disorders. Exp Dermatol. 2013;22(3):162–7.PubMedGoogle Scholar
  35. 35.
    Schuster V, Seregard S. Ligneous conjunctivitis. Surv Ophthalmol. 2003;48(4):369–88.PubMedGoogle Scholar
  36. 36.
    Fish R, Davidson RS. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol. 2010;21(4):317–21.PubMedGoogle Scholar
  37. 37.
    Sommer A, Vyas KS. A global clinical view on vitamin A and carotenoids. Am J Clin Nutr. 2012;96(5):1204S–6.PubMedGoogle Scholar
  38. 38.
    Koranyi G, Artzen D, Seregard S, Kopp ED. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Acta Ophthalmol. 2012;90(3):266–70.PubMedGoogle Scholar
  39. 39.
    Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small incision approach to pterygium surgery. Br J Ophthalmol. 2004;88(7):911–4.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Demirci H, Shields CL, Eagle Jr RC, Shields JA. Conjunctival amyloidosis: report of six cases and review of the literature. Surv Ophthalmol. 2006;51(4):419–33.PubMedGoogle Scholar
  41. 41.
    Shields JA, Eagle RC, Shields CL, et al. Systemic amyloidosis presenting as a mass of the conjunctival semilunar fold. Am J Ophthalmol. 2000;130(4):523–5.PubMedGoogle Scholar
  42. 42.
    Blancas-Mejia LM, Ramirez-Alvarado M. Systemic amyloidoses. Annu Rev Biochem. 2013;82:745–74.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Eagle RC. Conjunctiva. In: Eye pathology an atlas and text. 2nd ed. Philadelphia: Lippincott; 2011.Google Scholar
  44. 44.
    Yanoff M, Sassani JW. Conjunctiva. In: Ocular pathology. Edinburgh: Mosby Elsevier; 2009.Google Scholar
  45. 45.
    Sjo NC, von Buchwald C, Cassonnet P, et al. Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol. 2007;91(8):1014–5.PubMedCentralPubMedGoogle Scholar
  46. 46.
    Hughes EH, Intzedy L, Dick AD, Tole DM. Keratoacanthoma of the conjunctiva. Eye (Lond). 2003;17(6):781–2.Google Scholar
  47. 47.
    Cummings TJ, Dodd LG, Eedes CR, Klintworth GK. Hereditary benign intraepithelial dyskeratosis: an evaluation of diagnostic cytology. Arch Pathol Lab Med. 2008;132(8):1325–8.PubMedGoogle Scholar
  48. 48.
    Allingham RR, Seo B, Rampersaud E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet. 2001;68(2):491–4.PubMedCentralPubMedGoogle Scholar
  49. 49.
    Karcioglu ZA, Wagoner MD. Demographics, etiology, and behavior of conjunctival squamous cell carcinoma in the 21st century. Ophthalmology. 2009;116(11):2045–6.PubMedGoogle Scholar
  50. 50.
    Waddell K, Kwehangana J, Johnston WT, et al. A case-control study of ocular surface squamous neoplasia (OSSN) in Uganda. Int J Cancer. 2010;127(2):427–32.PubMedGoogle Scholar
  51. 51.
    Seregard S, Kock E. Squamous spindle cell carcinoma of the conjunctiva. Fatal outcome of a plerygium-like lesion. Acta Ophthalmol Scand. 1995;73(5):464–6.PubMedGoogle Scholar
  52. 52.
    Hwang IP, Jordan DR, Brownstein S, et al. Mucoepidermoid carcinoma of the conjunctiva: a series of three cases. Ophthalmology. 2000;107(4):801–5.PubMedGoogle Scholar
  53. 53.
    Robinson JW, Brownstein S, Jordan DR, Hodge WG. Conjunctival mucoepidermoid carcinoma in a patient with ocular cicatricial pemphigoid and a review of the literature. Surv Ophthalmol. 2006;51(5):513–9.PubMedGoogle Scholar
  54. 54.
    Lee CS, Yang WI, Shin KJ, Lee SC. Rapid growth of choroidal melanoma during pregnancy. Acta Ophthalmol. 2011;89(3):e290–1.PubMedGoogle Scholar
  55. 55.
    Say EA, Shields CL, Bianciotto C, et al. Oncocytic lesions (oncocytoma) of the ocular adnexa: report of 15 cases and review of literature. Ophthal Plast Reconstr Surg. 2012;28(1):14–21.PubMedGoogle Scholar
  56. 56.
    McKelvie PA, Daniell M, McNab A, et al. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol. 2002;86(2):168–73.PubMedCentralPubMedGoogle Scholar
  57. 57.
    AJCC. Cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  58. 58.
    Crossman G, Mowatt L, Jaggon J. Sebaceous gland hyperplasia of the caruncle: an uncommon diagnosis. Graefes Arch Clin Exp Ophthalmol. 2013;251:2259–60.PubMedGoogle Scholar
  59. 59.
    Bielory BP, Lari HB, Mirani N, et al. Conjunctival squamous cell carcinoma harboring Leishmania amastigotes in a human immunodeficiency virus-positive patient. Arch Ophthalmol. 2011;129(9):1230–1.PubMedGoogle Scholar
  60. 60.
    Longmuir S, Dumitrescu A, Kwon Y, et al. Juvenile xanthogranulomatosis with bilateral and multifocal ocular lesions of the iris, cornealscleral limbus, and choroid. J AAPOS. 2011;15(6):598–600.PubMedGoogle Scholar
  61. 61.
    Chaudhry IA, Al-Jishi Z, Shamsi FA, Riley F. Juvenile xanthogranuloma of the corneoscleral limbus: case report and review of the literature. Surv Ophthalmol. 2004;49(6):608–14.PubMedGoogle Scholar
  62. 62.
    Balestrazzi E, Ventura T, Delle Noci N, et al. Malignant conjunctival epibulbar fibrous histiocytoma with orbital invasion. Eur J Ophthalmol. 1991;1(1):23–7.PubMedGoogle Scholar
  63. 63.
    Shukla D, Kim R. Giant nodular posterior scleritis simulating choroidal melanoma. Indian J Ophthalmol. 2006;54(2):120–2.PubMedGoogle Scholar
  64. 64.
    Salomao D, Roden AC. Orbital pathology. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology. 3rd ed. Philadelphia: Saunders Elsevier; 2008.Google Scholar
  65. 65.
    Vezzosi D, Vignaux O, Dupin N, Bertherat J. Carney complex: clinical and genetic 2010 update. Ann Endocrinol (Paris). 2010;71(6):486–93.Google Scholar
  66. 66.
    Demirci H, Shields CL, Eagle Jr RC, Shields JA. Report of a conjunctival myxoma case and review of the literature. Arch Ophthalmol. 2006;124(5):735–8.PubMedGoogle Scholar
  67. 67.
    Mendez Mdel C, Muinos Y, Blanco G, et al. Embryonal rhabdomyosarcoma of the caruncle in a 4 year-old boy: case report. Arq Bras Oftalmol. 2012;75(3):207–9.PubMedGoogle Scholar
  68. 68.
    Freedman KA, Tran RM. Neurofibroma involving the caruncle. Arch Ophthalmol. 2004;122(2):294–5.PubMedGoogle Scholar
  69. 69.
    Demirci H, Shields CL, Bianciotto CG, Shields JA. Topical imiquimod for periocular lentigo maligna. Ophthalmology. 2010;117(12):2424–9.PubMedGoogle Scholar
  70. 70.
    Sehu KW, Lee WR. Conjunctiva. In: Ophthalmic pathology an illustrated guide for clinicians. Victoria: Blackwell; 2005.Google Scholar
  71. 71.
    Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114(3):501–10.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Schiby G, Polak-Charcon S, Mardoukh C, et al. Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization study. Hum Pathol. 2007;38(3):435–42.PubMedGoogle Scholar
  73. 73.
    Blasi MA, Tiberti AC, Valente P, et al. Intralesional interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results. Ophthalmology. 2012;119(3):494–500.PubMedGoogle Scholar
  74. 74.
    Kiratli H, Shields CL, Shields JA, DePotter P. Metastatic tumours to the conjunctiva: report of 10 cases. Br J Ophthalmol. 1996;80(1):5–8.PubMedCentralPubMedGoogle Scholar
  75. 75.
    Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology. 1989;96(4):436–61.PubMedGoogle Scholar
  76. 76.
    Gerner N, Norregaard JC, Jensen OA, Prause JU. Conjunctival naevi in Denmark 1960–1980. A 21-year follow-up study. Acta Ophthalmol Scand. 1996;74(4):334–7.PubMedGoogle Scholar
  77. 77.
    Vervaet N, Van Ginderdeuren R, Van Den Oord JJ, Foets B. A rare conjunctival Spitz nevus: a case report and literature review. Bull Soc Belge Ophtalmol. 2007;303:63–7.PubMedGoogle Scholar
  78. 78.
    Kantelip B, Boccard R, Nores JM, Bacin F. A case of conjunctival Spitz nevus: review of literature and comparison with cutaneous locations. Ann Ophthalmol. 1989;21(5):176–9.PubMedGoogle Scholar
  79. 79.
    Seregard S. Pigmented spindle cell naevus of reed presenting in the conjunctiva. Acta Ophthalmol Scand. 2000;78(1):104–6.PubMedGoogle Scholar
  80. 80.
    Demirci H, Shields CL, Shields JA, Eagle Jr RC. Malignant melanoma arising from unusual conjunctival blue nevus. Arch Ophthalmol. 2000;118(11):1581–4.PubMedGoogle Scholar
  81. 81.
    Berman EL, Shields CL, Sagoo MS, et al. Multifocal blue nevus of the conjunctiva. Surv Ophthalmol. 2008;53(1):41–9.PubMedGoogle Scholar
  82. 82.
    Seregard S, af Trampe E, Mansson-Brahme E, et al. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology. 1995;102(10):1524–9.PubMedGoogle Scholar
  83. 83.
    Bissig A, Moulin A, Spahn B, et al. Conjunctival pigmented epithelioid melanocytoma: a clinicopathological case report. Arch Ophthalmol. 2012;130(11):1478–9.PubMedGoogle Scholar
  84. 84.
    Jakobiec FA, Zuckerman BD, Berlin AJ, et al. Unusual melanocytic nevi of the conjunctiva. Am J Ophthalmol. 1985;100(1):100–13.PubMedGoogle Scholar
  85. 85.
    Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(2):180–4.PubMedGoogle Scholar
  86. 86.
    Toivonen P, Kivela T. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Ophthalmology. 2006;113(5):865–73.PubMedGoogle Scholar
  87. 87.
    Singh AD, De Potter P, Fijal BA, et al. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105(1):195–8.PubMedGoogle Scholar
  88. 88.
    Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42(4):321–50.PubMedGoogle Scholar
  89. 89.
    Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol. 1985;16(2):129–35.PubMedGoogle Scholar
  90. 90.
    Ackerman AB, Sood R, Koenig M. Primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol. 1991;4(2):253–63.PubMedGoogle Scholar
  91. 91.
    Folberg R, Jakobiec FA, McLean IW, Zimmerman LE. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol. 1992;5(1):2–5; discussion 6–8.PubMedGoogle Scholar
  92. 92.
    Damato B, Coupland SE. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Experiment Ophthalmol. 2008;36(8):786–95.PubMedGoogle Scholar
  93. 93.
    Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96(2):147–66.PubMedGoogle Scholar
  94. 94.
    Paridaens AD, McCartney AC, Hungerford JL. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol. 1992;76(3):163–5.PubMedCentralPubMedGoogle Scholar
  95. 95.
    Triay E, Bergman L, Nilsson B, et al. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol. 2009;93(11):1524–8.PubMedGoogle Scholar
  96. 96.
    Yu GP, Hu DN, McCormick S, Finger PT. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135(6):800–6.PubMedGoogle Scholar
  97. 97.
    Tuomaala S, Eskelin S, Tarkkanen A, Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43(11):3399–408.PubMedGoogle Scholar
  98. 98.
    Aoyagi M, Morishima N, Yoshino Y, et al. Conjunctival malignant melanoma with xeroderma pigmentosum. Ophthalmologica. 1993;206(3):162–7.PubMedGoogle Scholar
  99. 99.
    Paridaens AD, McCartney AC, Hungerford JL. Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum. Br J Ophthalmol. 1992;76(2):120–2.PubMedCentralPubMedGoogle Scholar
  100. 100.
    Seregard S, Triay E. New aspects on the pathogenesis of conjunctival melanoma. In: Reinhard T, editor. Essentials in ophthalmology. Berlin: Springer; 2007.Google Scholar
  101. 101.
    Jakobiec FA, Bhat P, Colby KA. Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol. 2010;128(2):174–83.PubMedGoogle Scholar
  102. 102.
    Jakobiec FA. The ultrastructure of conjunctival melanocytic tumors. Trans Am Ophthalmol Soc. 1984;82:599–752.PubMedCentralPubMedGoogle Scholar
  103. 103.
    Jeanniton C, Finger PT, Leung E, et al. Infected epithelial inclusion cyst simulating conjunctival melanoma. Ophthal Plast Reconstr Surg. 2013;29:e131–4.PubMedGoogle Scholar
  104. 104.
    Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol (Copenh). 1992;70(3):289–96.Google Scholar
  105. 105.
    Gear H, Williams H, Kemp EG, Roberts F. BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci. 2004;45(8):2484–8.PubMedGoogle Scholar
  106. 106.
    Spendlove HE, Damato BE, Humphreys J, et al. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 2004;14(6):449–52.PubMedGoogle Scholar
  107. 107.
    Goldenberg-Cohen N, Cohen Y, Rosenbaum E, et al. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci. 2005;46(9):3027–30.PubMedGoogle Scholar
  108. 108.
    Dratviman-Storobinsky O, Cohen Y, Frenkel S, et al. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51(12):6180–2.PubMedGoogle Scholar
  109. 109.
    Paridaens AD, McCartney AC, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994;78(7):520–8.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994;78(4):252–9.PubMedCentralPubMedGoogle Scholar
  111. 111.
    Tuomaala S, Toivonen P, Al-Jamal R, Kivela T. Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res. 2007;32(11):939–52.PubMedGoogle Scholar
  112. 112.
    Seregard S. Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am J Ophthalmol. 1993;116(1):93–7.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Stefan Seregard
    • 1
    Email author
  • Maria Antonietta Blasi
    • 2
  • Emilio Balestrazzi
    • 2
  1. 1.St Eriks Eye Hospital, Karolinska InstitutetStockholmSweden
  2. 2.Institute of Ophthalmology, Catholic UniversityRomeItaly

Personalised recommendations